The HDAC Inhibitors Market represents a dynamic and scientifically advanced segment of modern medicine, primarily focused on oncology. These epigenetic modulators work by altering gene expression, offering a targeted therapeutic approach distinct from traditional chemotherapy. With established success in treating certain hematologic malignancies and ongoing research into a broader range of...